Startups

ViaNautis
ViaNautis develops polymer nanovesicles that deliver genetic medicines to selected cells, including targets in the brain and spinal cord.
Startups

ViaNautis develops polymer nanovesicles that deliver genetic medicines to selected cells, including targets in the brain and spinal cord.